M
LGND icon

Murchinson’s Ligand Pharmaceuticals LGND Stock Holding History

Murchinson’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-59,984
Closed -$5.21M – 154
2021
Q3 		$5.21M Sell
59,984
-27,864
-32% -$2.16M 2.59% 15
2021
Q2 		$7.19M Buy
+87,848
New +$7.31M 2.58% 9

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Murchinson's LGND Position: Q4 2021 in Review

Murchinson sold out of Ligand Pharmaceuticals (LGND) in Q4 2021, closing a stake of 59,984 shares — an estimated $5.21M sold.

Murchinson first reported a position in LGND in Q2 2021 and held it in 2 quarters. The position peaked at $7.19M in Q2 2021. 221 funds tracked by Wall St. Rank hold LGND as of Q4 2021.

  • Murchinson reported no remaining Ligand Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Murchinson sold 59,984 Ligand Pharmaceuticals shares in Q4 2021, an estimated $5.21M.
  • Murchinson first reported a position in Ligand Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Murchinson's Ligand Pharmaceuticals position peaked at $7.19M in Q2 2021.
  • 221 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2021.

Based on Murchinson's 13F filing for Q4 2021, filed 14 Feb 2022.